Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

8(88.9%)

Phase 1

1(11.1%)

9Total

N/A(8)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06802068Not ApplicableCompleted

Change in Omega 3 Index in Healthy Adults With OmeGo or a Standard Omega-3 Oil Supplement

Role: lead

NCT05130294Not ApplicableWithdrawn

Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease

Role: lead

NCT05137132Not ApplicableCompleted

Unrefined Salmon Oil as Dietary Supplement in Adult Asthmatics

Role: lead

NCT07119645Not ApplicableNot Yet Recruiting

NT-II™ Collagen for Joint Discomfort and Function

Role: lead

NCT05066477Not ApplicableCompleted

A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women

Role: lead

NCT06768970Not ApplicableCompleted

Investigating the Effect of Daily CARDIO® Capsules Supplementation on Improved Sleep in Healthy, Urban-Dwelling Adults

Role: lead

NCT05070871Not ApplicableCompleted

A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women

Role: lead

NCT04465513Not ApplicableCompleted

Investigation of the Efficacy of CARDIO Softgels PLUS Best-standard-of-care in the Recovery of Patients With COVID-19

Role: lead

NCT03535571Phase 1Completed

A Study to Evaluate the Efficacy of Salmon Protein Hydrolysate Powder on Energy Increase and Anti-inflammatory Modulation in Healthy Males and Females

Role: lead

All 9 trials loaded